MetaADEDB 2.0 @ LMMD
Angiotensin II
(CZGUSIXMZVURDU-JZXHSEFVSA-N)
Structure
SMILES
CC[C@@H]([C@@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(=O)O)Cc1ccccc1)Cc1[nH]cnc1)NC(=O)[C@@H](NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)N)CCCN=C(N)N)Cc1ccc(cc1)O)C
Type(s)
Approved; Investigational
ATC code(s)
C01CX09
Molecular Formula:
C50H71N13O12
Molecular Weight:
1046.180
Log P:
3.0695
Hydrogen Bond Acceptor:
24
Hydrogen Bond Donor:
13
TPSA:
408.84
CAS Number(s):
4474-91-3; 11128-99-7
Synonym(s)
1.
Angiotensin II
2.
Angiotensin II, Ile(5)-
3.
Angiotensin II, Val(5)-
4.
5-L-Isoleucine Angiotensin II
5.
ANG-(1-8)Octapeptide
6.
Angiotensin II, Isoleucine(5)-
7.
Angiotensin II, Valine(5)-
8.
Angiotensin-(1-8) Octapeptide
9.
Isoleucine(5)-Angiotensin
10.
Isoleucyl(5)-Angiotensin II
11.
Valyl(5)-Angiotensin II
12.
5 L Isoleucine Angiotensin II
13.
Angiotensin II, 5-L-Isoleucine
External Link(s)
MeSHD000804
PubChem Compound45266664
172198
BindingDB50236697
50228195
ChEBI58506
2719
131170
CHEMBLCHEMBL408403
DrugBankDB11842
DrugCentral5272
IUPHAR/BPS Guide to PHARMACOLOGY2504
KEGGcpd:C02135
dr:D02014
Therapeutic Target DatabaseD0G6SE
ZINC169676920
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1CyanosisFAERS: 1US FAERS
2Disseminated Intravascular CoagulationFAERS: 1US FAERS
3Portal Vein ThrombosisFAERS: 1US FAERS
4Septic ShockFAERS: 1US FAERS
5ThrombosisFAERS: 1US FAERS
6Kidney Diseases12969123CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.